Patient-specific dendritic cell vaccines with autologous tumor antigens in 72 patients with metastatic melanoma

Aim: Metastatic melanoma patients were treated with patient-specific vaccines consisting of autologous dendritic cells loaded with antigens from irradiated cells from short-term autologous tumor cell lines.